a year ago
ARDX
AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Analyst Ranking
Bottom 9%
#4446 out of 4861 analysts
Average Return
-3.18%
Win Rate
31%48 out of 153
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +658.28% | $5.13 | $38.90 | 2023-10-11 - 2024-10-11 | Buy |
Edgewise Therapeutics IncEWTX | +560.25% | $5.51 | $36.38 | 2023-11-09 - 2024-11-08 | Buy |
Longboard Pharmaceuticals IncLBPH | +200.50% | $19.96 | $59.98 | 2024-03-12 - 2024-11-29 | Buy |
Longboard Pharmaceuticals IncLBPH | +180.61% | $21.38 | $59.98 | 2024-05-02 - 2024-11-29 | Buy |
Travere Therapeutics IncTVTX | +179.39% | $8.20 | $22.91 | 2024-02-15 - 2025-02-14 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tourmaline Bio IncTRML | 2 | Buy | $43.00 | +168.58% | Maintains | a month ago |
Vigil Neuroscience IncVIGL | 9 | Buy | $13.00 | +660.23% | Maintains | a month ago |
Gossamer Bio IncGOSS | 4 | Buy | $4.00 | +374.50% | Reiterates | a month ago |
Ovid Therapeutics IncOVID | 2 | Buy | $3.00 | +938.06% | Maintains | a month ago |
Dianthus Therapeutics IncDNTH | 6 | Buy | $36.00 | +84.62% | Reiterates | a month ago |
Astria Therapeutics IncATXS | 9 | Buy | $28.00 | +593.07% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 13 | Hold | $29.00 | +59.34% | Maintains | 2 months ago |
Sage Therapeutics IncSAGE | 7 | Hold | $6.00 | -19.25% | Reiterates | 2 months ago |
Neurocrine Biosciences IncNBIX | 9 | Buy | $147.00 | +45.00% | Maintains | 2 months ago |
Solid Biosciences IncSLDB | 1 | Buy | $16.00 | +527.45% | Initiates Coverage On | 4 months ago |
Edgewise Therapeutics IncEWTX | 9 | Buy | $45.00 | +234.57% | Maintains | 5 months ago |
Pepgen IncPEPG | 10 | Buy | $12.00 | +802.26% | Maintains | 5 months ago |
Vera Therapeutics IncVERA | 7 | Hold | $38.00 | +78.49% | Maintains | 5 months ago |
Alto Neuroscience IncANRO | 3 | Hold | $4.00 | +76.99% | Downgrades | 6 months ago |
Travere Therapeutics IncTVTX | 9 | Buy | $25.00 | +67.56% | Maintains | 6 months ago |
Larimar Therapeutics IncLRMR | 1 | Buy | $22.00 | +1,051.83% | Initiates Coverage On | 7 months ago |
Biogen IncBIIB | 14 | Hold | $205.00 | +72.84% | Maintains | 7 months ago |
Longboard Pharmaceuticals IncLBPH | 7 | Buy | $44.00 | -26.64% | Maintains | 7 months ago |
Praxis Precision Medicines IncPRAX | 6 | Hold | $48.00 | +42.05% | Maintains | 8 months ago |
Xenon Pharmaceuticals IncXENE | 8 | Buy | $49.00 | +39.56% | Maintains | 8 months ago |
Voyager Therapeutics IncVYGR | 3 | Hold | $7.00 | +121.52% | Maintains | 8 months ago |
Denali Therapeutics IncDNLI | 7 | Buy | $26.00 | +104.08% | Maintains | 9 months ago |
Ultragenyx Pharmaceutical IncRARE | 11 | Hold | $46.00 | +28.89% | Maintains | 9 months ago |
Ardelyx IncARDX | 13 | Buy | $11.00 | +128.45% | Reiterates | 9 months ago |
Viridian Therapeutics IncVRDN | 7 | Buy | $42.00 | +219.88% | Reiterates | 9 months ago |
Stoke Therapeutics IncSTOK | 6 | Buy | $17.00 | +121.07% | Reiterates | 9 months ago |
Aerovate Therapeutics IncAVTE | 3 | Buy | $41.00 | +1,390.91% | Reiterates | 10 months ago |
Pharvaris NvPHVS | 5 | Buy | $31.00 | +121.43% | Maintains | a year ago |
Rallybio CorpRLYB | 4 | Buy | $11.00 | N/A | Maintains | a year ago |
Design Therapeutics IncDSGN | 5 | Hold | $5.00 | N/A | Reiterates | a year ago |
Karuna Therapeutics IncKRTX | 4 | Hold | $330.00 | N/A | Downgrades | a year ago |
Chinook Therapeutics IncKDNY | 3 | Hold | $42.00 | N/A | Downgrades | 2 years ago |
Impel Pharmaceuticals IncIMPLQ | 2 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | N/A | Downgrades | 3 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 6 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 7 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $720.00 | N/A | Initiates Coverage On | 7 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.